Northern Trust’s Fennec Pharmaceuticals FENC Stock Holding History

Northern Trust’s Portfolio FENC Stock Details FENC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$936K	Buy	152,123 +40,031	+36%	+$309K	﹤0.01%	3372
2025 Q4	$863K	Sell	112,092 -18,461	-14%	-$152K	﹤0.01%	3445
2025 Q3	$1.22M	Sell	130,553 -919	-0.7%	-$7.96K	﹤0.01%	3304
2025 Q2	$1.09M	Sell	131,472 -6,903	-5%	-$47.2K	﹤0.01%	3334
2025 Q1	$843K	Buy	138,375 +1,620	+1%	+$10.4K	﹤0.01%	3353
2024 Q4	$864K	Sell	136,755 -2,976	-2%	-$15.2K	﹤0.01%	3456
2024 Q3	$699K	Buy	139,731 +33,332	+31%	+$193K	﹤0.01%	3476
2024 Q2	$650K	Sell	106,399 -7,669	-7%	-$63.7K	﹤0.01%	3407
2024 Q1	$1.27M	Buy	114,068 +2,308	+2%	+$23.2K	﹤0.01%	3207
2023 Q4	$1.25M	Buy	111,760 +897	+0.8%	+$7.43K	﹤0.01%	3234
2023 Q3	$833K	Sell	110,863 -3,620	-3%	-$29.5K	﹤0.01%	3357
2023 Q2	$1.01M	Buy	+114,483	New	+$952K	﹤0.01%	3358
2021 Q2	–	Sell	-182,107	Closed	-$1.13M	–	4607
2021 Q1	$1.13M	Sell	182,107 -21,892	-11%	-$165K	﹤0.01%	3532
2020 Q4	$1.52M	Sell	203,999 -2,635	-1%	-$20.1K	﹤0.01%	3332
2020 Q3	$1.25M	Sell	206,634 -10,226	-5%	-$72.1K	﹤0.01%	3290
2020 Q2	$1.81M	Buy	+216,860	New	+$1.61M	﹤0.01%	3090
2019 Q3	–	Sell	-96,972	Closed	-$388K	–	4265
2019 Q2	$388K	Sell	96,972 -5,105	-5%	-$21.6K	﹤0.01%	3624
2019 Q1	$495K	Buy	102,077 +220	+0.2%	+$1.45K	﹤0.01%	3540
2018 Q4	$650K	Sell	101,857 -228	-0.2%	-$1.59K	﹤0.01%	3496
2018 Q3	$837K	Buy	102,085 +753	+0.7%	+$6.99K	﹤0.01%	3517
2018 Q2	$1.06M	Buy	+101,332	New	+$1.2M	﹤0.01%	3441

Other funds holding FENC

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

SCA

Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return

SCM

Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Potomac Capital Management New York $115M AUM

Northern Trust's FENC Position: Q1 2026 in Review

Northern Trust increased its Fennec Pharmaceuticals (FENC) stake by 36% in Q1 2026, buying an estimated $309K and bringing the position to 152,123 shares worth $936K. The position accounts for ﹤0.01% of the portfolio, ranked #3372.

Northern Trust first reported a position in FENC in Q2 2018 and has held it in 21 quarters since. The position peaked at $1.81M in Q2 2020. 90 funds tracked by Wall St. Rank hold FENC as of Q1 2026.

Northern Trust held 152,123 shares of Fennec Pharmaceuticals worth $936K as of Q1 2026.
Northern Trust bought 40,031 Fennec Pharmaceuticals shares in Q1 2026, an estimated $309K.
Fennec Pharmaceuticals made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3372 holding.
Northern Trust first reported a position in Fennec Pharmaceuticals in Q2 2018 and has held it in 21 quarters since.
Northern Trust's Fennec Pharmaceuticals position peaked at $1.81M in Q2 2020.
90 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.